Randomized, phase III study of weekly paclitaxel in combination with carboplatin versus standard every-3-weeks administration of carboplatin and paclitaxel for patients with previously untreated advanced non-small-cell lung cancer

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Chandra P BelaniWilliam J Tester

Abstract

To compare the efficacy and safety of weekly paclitaxel in combination with carboplatin administered every 4 weeks to the standard regimen of paclitaxel and carboplatin administered every 3 weeks for the treatment of patients with advanced non-small-cell lung cancer (NSCLC). Four hundred forty-four patients with previously untreated stage IIIB/IV NSCLC were randomly assigned to either arm 1 (n = 223), paclitaxel 100 mg/m(2) weekly for 3 of 4 weeks with carboplatin area under the curve (AUC) = 6 mg/mL x min on day 1 of each 4 week cycle, or arm 2 (n = 221), paclitaxel 225 mg/m(2) and carboplatin AUC = 6 on day 1 of each 3-week cycle. After four cycles of therapy, patients in both treatment arms were eligible to continue weekly paclitaxel (70 mg/m(2), 3 of 4 weeks) as maintenance therapy until unacceptable toxicity or disease progression. The objective response rate was 27.6% for arm 1 and 19.2% for arm 2. Median time to progression (TTP) was 18.4 and median survival (MS) was 38.6 weeks for arm 1. For arm 2, the median TTP and MS were 16.7 weeks and 42.9 weeks respectively. Grade 3/4 anemia was more common with arm 1, although grade 2/3 neuropathy and arthralgia were less common. The remainder of the toxicities were similar betwe...Continue Reading

References

Mar 7, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·I E SmithS Ashley
Apr 17, 2001·Annals of Internal Medicine·D G AltmanUNKNOWN CONSORT GROUP (Consolidated Standards of Reporting Trials)
Jan 11, 2002·The New England Journal of Medicine·Joan H SchillerUNKNOWN Eastern Cooperative Oncology Group
Feb 16, 2002·Journal of Hematotherapy & Stem Cell Research·Angelo VaccaFranco Dammacco
Mar 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mark A SocinskiMerrill S Kies
Jul 30, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Chandra P BelaniGlenn M Mills
Feb 26, 2004·Seminars in Oncology·Sakkaraiappan Ramalingam, Chandra P Belani
Apr 30, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C P BelaniR B Natale
Oct 27, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M A SocinskiH B Niell
Dec 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stephen K WilliamsonUNKNOWN Southwest Oncology Group Trial S0003
Sep 30, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ramaswamy GovindanJay Piccirillo
Dec 15, 2006·The New England Journal of Medicine·Alan SandlerDavid H Johnson
Jan 24, 2007·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun

❮ Previous
Next ❯

Citations

Mar 5, 2011·Cancer Chemotherapy and Pharmacology·Lakshmi RajdevJoseph A Sparano
Mar 24, 2007·International Journal of Clinical Oncology·Angeles Alvarez SecordAndrew Berchuck
May 19, 2009·Current Treatment Options in Oncology·Jared Weiss, Corey Langer
Jul 22, 2011·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Dolores IslaHenrik W Finnern
Feb 4, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M A SocinskiP J Stella
Jul 12, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M A SocinskiM F Renschler
Nov 18, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christopher G AzzoliUNKNOWN American Society of Clinical Oncology
Nov 26, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Suresh S RamalingamChandra P Belani
Jun 23, 2011·Clinical Medicine Insights. Oncology·Bryan A Faller, Trailokya N Pandit
Jul 3, 2013·Evidence-based Complementary and Alternative Medicine : ECAM·Chun LiMing Q Wei
Jun 22, 2014·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Celia M Bridges, Ellen M Lavoie Smith
Dec 14, 2011·Revue des maladies respiratoires·S MarcoF Barlesi
Sep 27, 2012·International Journal of Clinical Oncology·Patricia M M B SoetekouwVivianne C G Tjan-Heijnen
May 13, 2010·Investigational New Drugs·Mark Andrew DicksonGary K Schwartz
Feb 18, 2011·Investigational New Drugs·Michael MillwardMatthew A Spear
Feb 15, 2016·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Liza C Villaruz, Mark A Socinski
Sep 25, 2015·Expert Review of Anticancer Therapy·Mariateresa LapresaNicoletta Colombo
Mar 24, 2015·Expert Opinion on Pharmacotherapy·Bianca A M H van VeggelEgbert F Smit
Nov 15, 2014·Expert Opinion on Drug Metabolism & Toxicology·Markus Joerger
Nov 8, 2015·Advanced Drug Delivery Reviews·Quanyin HuZhen Gu
Nov 22, 2015·Cancer Chemotherapy and Pharmacology·Markus Joerger
Aug 19, 2011·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Shair AhmedThomas Ng
Dec 19, 2013·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Vera HirshMark A Socinski
Jan 6, 2011·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Charles H WeissmanLina Asmar
Mar 8, 2011·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Tobias Engel Ayer BotrelBruna Pegoretti
May 11, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Sandro Pignata
Sep 3, 2008·Critical Reviews in Oncology/hematology·Laura BiganzoliAngelo Di Leo
Aug 7, 2009·Cancer·Tony S K Mok, Suresh S Ramalingam

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.